Tag Archive for PRO/AH/EDR> COVID-19 update (46): vaccine, mAb, diabetes, age, WHO
PRO/AH/EDR> COVID-19 update (46): vaccine, mAb, diabetes, age, WHO
COVID-19 -- RussiaSummary-------BackgroundA heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), showed a good safety profile and induced strong humoral and cellular immune responses in participants in phase 1/2 clinical trials. Here, we report preliminary results on the efficacy and safety of Gam-COVID-Vac from the interim analysis of this phase 3 trial.MethodsWe did a randomised, double-blind, placebo-controlled, phase 3 trial at 25 hospitals and polyclinics in Read more [...]
